phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Bone Cancer

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halmos, G; Letsch, M; Nagy, A; Schally, AV; Szepeshazi, K	1

Other Studies

1 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Bone Cancer

Article	Year
Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238. The Journal of urology, 2004, Volume: 171, Issue:2 Pt 1 Topics: Androgens; Animals; Bone Neoplasms; Cell Line, Tumor; Cytotoxins; Doxorubicin; Drug Carriers; Humans; Male; Mice; Mice, Nude; Octreotide; Prostatic Neoplasms; Pyrroles; Somatostatin	2004

Article

Year

Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238.

The Journal of urology, 2004, Volume: 171, Issue:2 Pt 1

Topics: Androgens; Animals; Bone Neoplasms; Cell Line, Tumor; Cytotoxins; Doxorubicin; Drug Carriers; Humans; Male; Mice; Mice, Nude; Octreotide; Prostatic Neoplasms; Pyrroles; Somatostatin

2004